Sumit chrono
7 months ago
Stem cell therapy for Stargardt's disease in India: regulation, research and what to expect
This guide looks at how stem cell therapy for Stargardt's disease is regulated in India, what research is realistic, and how Indian patients can follow legitimate trials at home and abroad.
Stem cell therapy for Stargardt's disease: the Indian picture
Most clinical research on stem cell therapy for Stargardt's disease has been done in other countries, mainly with RPE cells grown from stem cells. Indian patients usually follow this research through registries and their retina specialist rather than through approved local treatment.
India has strong eye institutes, genetic testing services and a formal regulatory framework, so careful, registered research is possible. What is not appropriate is a routine, paid procedure presented as an established cure.
How stem cell therapy is regulated in India
Several bodies and rules work together.
CDSCO and drug rules
Stem cell-derived products are regulated as new drugs under the New Drugs and Clinical Trials Rules, 2019.
ICMR–DBT guidelines
The national guidelines treat most stem cell use as investigational, requiring a registered, approved trial.
Institutional oversight
Institutions need IC-SCR and ethics committee approval for stem cell work.
CTRI registration
Indian clinical trials must be listed on the public Clinical Trials Registry – India.
What is realistic to expect
Keep expectations grounded.
Early-phase research
Current studies mostly test safety and feasibility in small groups.
Uncertain benefit
Any gain in vision is not guaranteed, and results have varied.
Strict eligibility
Trials usually require a confirmed diagnosis, a particular stage and a stable general health.
Other options progressing
Gene therapy and oral medicines are also in trials, so ask which route suits your gene change.
How to follow legitimate research from India
Practical steps for patients and families.
- Search the registriesUse CTRI for Indian studies and ClinicalTrials.gov for international ones.
- Ask your retina specialistThey can judge whether a study fits your gene change and stage.
- Get a genetic report readyAn ABCA4 result and clear scans make it easier to be assessed for any trial.
- Be careful about travelling abroadConfirm the trial is registered, ethics-approved and free of payment for the experimental procedure before you travel.
Risks of unproven procedures
The eye needs particular caution.
Infection and detachment
Injections or surgery in the eye can cause serious complications.
Immune reactions
Donor cells can provoke inflammation or rejection.
Permanent vision loss
Damage to the macula cannot usually be reversed.
Lost trial eligibility
An unproven procedure may rule you out of legitimate studies later.
Our Medical Experts – Trusted Specialists
Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.
Dr. Pallavi
Senior Consultant | Ophthalmologist & Eye Surgeon22+ Years ExperienceDr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.
Get ConsultationDr. Robin
Consultant Ophthalmologist & Eye Surgeon | MD, DO16+ Years ExperienceDr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.
Get ConsultationDr. Pawan
Associate Professor | Vitreo-Retina Surgeon10+ Years ExperienceDr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.
Get ConsultationFrequently asked questions
Is stem cell therapy for Stargardt's disease approved in India?
No. No stem cell therapy for Stargardt's disease currently holds CDSCO approval as a proven, routine treatment.
Who regulates stem cell therapy in India?
CDSCO regulates stem cell-derived products, while ICMR and the Department of Biotechnology publish the national guidelines for stem cell research.
Can I join an international trial from India?
Sometimes. Entry depends on eligibility criteria and travel arrangements, so discuss it with your retina specialist and verify the trial first.
Is stem cell therapy for Stargardt's disease better than gene therapy?
No approach is proven yet. Both are being studied, and the best option may depend on your gene change and stage.
